Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Want to see HK:9989 full AI Analyst Report?
Comparison Results
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
HK$5.19
HK$16.60B
8.36
7.85%
―
HUTCHMED (China)
HK$21.18
HK$18.35B
―
-12.33%
10 Buy
0 Hold
1 Sell
Strong Buy
Shanghai Fosun Pharmaceutical (Group) Co
HK$19.63
HK$70.96B
13.21
39.03%
2 Buy
0 Hold
0 Sell
Moderate Buy
China Resources Pharmaceutical Group Ltd.
HK$4.61
HK$32.42B
3.24
5.31%
6 Buy
0 Hold
0 Sell
Strong Buy
CanSino Biologics, Inc. Class H
HK$44.94
HK$11.94B
-42.31
-12.84%
―
Performance Comparison
HK:9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
4.81
0.52
12.12%
HK:0013
HUTCHMED (China)
21.04
-2.36
-10.09%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
19.13
5.46
39.92%
HK:3320
China Resources Pharmaceutical Group Ltd.
5.16
0.33
6.90%
HK:1558
―
―
―
―
HK:6185
CanSino Biologics, Inc. Class H
29.20
-3.80
-11.52%